Search
Search Results
-
Efficacy of oral ferric citrate hydrate treatment for anemia caused by niraparib: a case report
BackgroundMaintenance therapy using poly(adenosine diphosphate-ribose)polymerase inhibitors may have adverse events, including hematological...
-
Effect of ferric citrate hydrate on fibroblast growth factor 23 and platelets in non-dialysis-dependent chronic kidney disease and non-chronic kidney disease patients with iron deficiency anemia
BackgroundIron deficiency anemia (IDA) increases levels of C-terminal fibroblast growth factor 23 (cFGF23) and platelet count (PLT), each of which is...
-
Iron absorption and phosphate-lowering effects of ferric citrate hydrate are not influenced by gastric acid secretion inhibitors in patients with chronic kidney disease: a retrospective post hoc analysis
BackgroundFerric citrate hydrate (FC), an oral iron product is approved as iron preparation for iron deficiency anemia and phosphate binder for...
-
Effects of ferric citrate hydrate in patients with chronic kidney disease and heart failure: subgroup analysis of a long-term, real-world, post-marketing surveillance study
BackgroundIron deficiency is widely present in patients with heart failure (HF) and is associated with an increased risk of mortality and poor...
-
Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study
BackgroundFerric citrate hydrate (FC) is an oral iron-based phosphate binder that is used to treat hyperphosphatemia in patients with chronic kidney...
-
Association of fibroblast growth factor 23 and α-klotho in hemodialysis patients during administration of ferric citrate hydrate: post hoc analysis of ASTRIO study
BackgroundFibroblast growth factor-23 (FGF23) and α-klotho are associated with anemia in patients with chronic kidney disease. In this post hoc...
-
Efficacy and safety of ferric citrate hydrate compared with sodium ferrous citrate in Japanese patients with iron deficiency anemia: a randomized, double-blind, phase 3 non-inferiority study
Oral iron preparations are used as first-line treatment for iron deficiency anemia (IDA), but their gastrointestinal side effects prevent patients...
-
Long-term efficacy and safety of iron-based phosphate binders, ferric citrate hydrate and sucroferric oxyhydroxide, in hemodialysis patients
PurposeIron-based phosphate binders, including ferric citrate hydrate (FCH) and sucroferric oxyhydroxide (SFOH), have been used for the treatment of...
-
Regional prescription surveillance of phosphate binders in the western Saitama area: the substantial role of ferric citrate hydrate in improving serum phosphorus levels and erythropoiesis
BackgroundIn April 2015, five types of phosphate binders (PBs) were available by prescription in Japan, namely calcium carbonate, sevelamer...
-
Mechanism of Action and Clinical Attributes of Auryxia® (Ferric Citrate)
Chronic kidney disease (CKD) is a major cause of morbidity and premature mortality and represents a significant global public health issue....
-
The modulation of iron metabolism affects the Rhabdomyosarcoma tumor growth in vitro and in vivo
Rhabdomyosarcoma (RMS) is an aggressive rare neoplasm that derives from mesenchymal cells, which frequently develops resistance to the current...
-
Iron accumulation deteriorated bone loss in estrogen-deficient rats
BackgroundPostmenopausal osteoporosis is characterized by an imbalance of bone resorption exceeding bone formation, resulting in a net loss of bone...
-
A comparison between the combined effect of calcium carbonate with sucroferric oxyhydroxide and other phosphate binders: an in vitro and in vivo experimental study
BackgroundApproximately 30% of patients on dialysis received combination therapy for their phosphate binder prescription; however, few studies for...
-
Correction to: Regional prescription surveillance of phosphate binders in the western Saitama area: the substantial role of ferric citrate hydrate in improving serum phosphorus levels and erythropoiesis
In the Original publication, Under the table 1, the number of participants in the April has been incorrectly published as 1373. The corrected table...
-
Calcium polystyrene sulfonate-induced rectal ulcer causing E. coli native-valve infective endocarditis
Escherichia coli -associated native-valve infective endocarditis is a rare disease that affects elderly patients with underlying risk factors such as...
-
Endoscopic clip-induced acute appendicitis in a patient on chronic hemodialysis: a case report with literature review
BackgroundForeign body-induced acute appendicitis is rare but could most often be caused by fish bones; those caused by endoscopic clips are highly...
-
Effect of ferric citrate hydrate on FGF23 and PTH levels in patients with non-dialysis-dependent chronic kidney disease with normophosphatemia and iron deficiency
BackgroundIn patients with normophosphatemia with chronic kidney disease (CKD), fibroblast growth factor 23 (FGF23) and parathyroid hormone (PTH)...
